Results 1 to 10 of about 10,538,494 (333)
Ileal and colonic Crohn's disease: Does location makes a difference in therapy efficacy?
Current Research in Pharmacology and Drug Discovery, 2022 Within the IBD entity of Crohn's disease, there is currently no differentiation between ileal and colonic manifestation for recruitment of patients in clinical trials, well-powered analysis of study results or therapeutic decisions in daily clinical ...
Raja Atreya +5 more
doaj +1 more source
Crohn's disease what we know about it, symptoms, diagnosis, treatment
Journal of Education, Health and Sport, 2023 Crohn's disease is a chronic disease. It most often begins between the ages of 15 and 35 and lasts a lifetime. The earliest radiographic findings are aphthous ulcers. It can cause mouth-to-anal lesions and extra-intestinal complications. Typical symptoms
Monika Sosna +2 more
doaj +1 more source
Knife cut fissures: A clue for vulval crohn's disease!!
Clinical Dermatology Review, 2021 Crohn's disease is an inflammatory bowel disorder with various extraintestinal manifestations. Vulva is rarely involved in Crohn's disease and occasionally may constitute the only sign of the disease.
M L Ranjitha +3 more
doaj +1 more source
Crohn's disease - diagnosis and treatment
Journal of Education, Health and Sport, 2021 AdmissionCrohn's disease belongs to the group of chronic and still incurable diseases. It has periods of exacerbation and partial or complete remission. It mainly affects young people.
Patrycja Ręba
doaj +1 more source
Crohn's disease or Crohn's diseases? [PDF]
Gut, 2003 Disease behaviour in Crohn’s disease is dynamic and not stable over time In their landmark paper of 1932, Crohn, Ginzburg, and Oppenheimer1 described “a disease of the terminal ileum, affecting mainly young adults and characterised by a subacute or chronic necrotising and cicratrising inflammation.
Arnott, IDR, Satsangi, J
openaire +3 more sources
The Predictive Value of Periostin to Diagnose Crohn’s Disease
The Turkish Journal of Gastroenterology, 2022 Background: There is still no sensitive and specific biomarker that can be used in the diagnosis and follow-up of Crohn’s disease, so we aimed to assess the diagnostic accuracy of serum periostin levels in Crohn’s disease.
Muharrem Keskin, Ali Topkaç
doaj +1 more source
European Journal of Surgery, 2003 EMM: Coloproctology presents the state-of-the-art in coloproctology. The topics covered include anatomy, physiology, anal disorders, dermatology, functional disorders, inflammatory bowel disease, b ...
R, Sjödahl, G, Järnerot
+6 more sources
Case Reports in Gastrointestinal Medicine, 2022 Whereas typical Crohn’s disease is confined to the terminal ileum and presents with abdominal pain and diarrhea, gastroduodenal manifestations of Crohn’s disease are rare, with often asymptomatic patient presentations and inconclusive diagnostic testing.
Clive Jude Miranda +4 more
doaj +1 more source
Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.
New England Journal of Medicine, 2023 BACKGROUND Upadacitinib, an oral selective Janus kinase (JAK) inhibitor, is under investigation for the treatment of Crohn's disease. METHODS In two phase 3 induction trials (U-EXCEL and U-EXCEED), we randomly assigned patients with moderate-to-severe ...
E. Loftus +18 more
semanticscholar +1 more source
PLoS ONE, 2021 The burden of inflammatory bowel disease (IBD) in Australia is increasing but national data about the current prevalence are limited. We aimed to estimate the prevalence of IBD (including Crohn's disease, ulcerative colitis and unspecified IBD) as well ...
Doreen Busingye +2 more
doaj +1 more source